FDA recall, , Moderate risk
American National Red Cross Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced failed a monthly QC residual white blood cell count.
Recall ended Aug 4, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross recalled Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced distributed in Illinois because the product, labeled as leukocytes reduced, failed the monthly QC residual white blood cell count. The recall began February 18, 2025, and was added to the FDA's Enforcement Report on August 4, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
Recall details
- Company began the recall
- Sold in
- Company
- American National Red Cross (the)
- Hazard
- Labeling error
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99394
- Recall number
- B-0167-2026
All recalls from American National Red Cross (the)
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
